Literature DB >> 2732340

Sclerosing cholangitis with hepatic microvesicular steatosis in cystic fibrosis and chronic pancreatitis.

I Benett1, B Salh, N Y Haboubi, J M Braganza.   

Abstract

The association between asymptomatic primary sclerosing cholangitis and exocrine pancreatic disease was underlined by the findings in a patient with cystic fibrosis and in another with chronic pancreatitis. In each case hepatocytes showed extensive microvesicular steatosis and studies of drug metabolism suggested hepatic enzyme induction: biliary or serum analysis, or both, disclosed raised concentrations of a lipid-based marker of free radical oxidation. These findings suggest that toxic metabolites of oxygen or other chemicals may have a role in the pathogenesis of the bile duct lesion.

Entities:  

Mesh:

Year:  1989        PMID: 2732340      PMCID: PMC1141950          DOI: 10.1136/jcp.42.5.466

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  17 in total

1.  ULTRASTRUCTURAL CHANGES OF THE PANCREAS AND LIVER IN CYSTIC FIBROSIS.

Authors:  E A PORTA; A A STEIN; P PATTERSON
Journal:  Am J Clin Pathol       Date:  1964-11       Impact factor: 2.493

Review 2.  The role of the liver in exocrine pancreatic disease.

Authors:  J M Braganza
Journal:  Int J Pancreatol       Date:  1988

3.  Chronic pancreatitis, HLA and autoimmunity.

Authors:  R J Anderson; P A Dyer; D Donnai; P T Klouda; R Jennison; J M Braganza
Journal:  Int J Pancreatol       Date:  1988 Jan-Feb

4.  Altered liver histology in patients with pancreatitis: a clue to etiology?

Authors:  N Y Haboubi; H H Ali; J M Braganza
Journal:  Mt Sinai J Med       Date:  1986-05

Review 5.  Nuclear magnetic resonance spectroscopy in the study of inborn errors of metabolism.

Authors:  R A Iles; R A Chalmers
Journal:  Clin Sci (Lond)       Date:  1988-01       Impact factor: 6.124

6.  An evaluation of the low-pH enzymatic assay of urinary D-glucaric acid, and its use as a marker of enzyme induction in exocrine pancreatic disease.

Authors:  L N Sandle; J M Braganza
Journal:  Clin Chim Acta       Date:  1987-02-15       Impact factor: 3.786

7.  Sclerosing-cholangitis-like changes in pancreatic disease.

Authors:  F Warwick; R J Anderson; J M Braganza
Journal:  Clin Radiol       Date:  1985-01       Impact factor: 2.350

Review 8.  Occupational chemicals and pancreatitis: a link?

Authors:  J M Braganza; J E Jolley; W R Lee
Journal:  Int J Pancreatol       Date:  1986-05

9.  Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis.

Authors:  R W Chapman; P M Kelly; A Heryet; D P Jewell; K A Fleming
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

10.  Sclerosing cholangitis associated with hepatic arterial FUDR chemotherapy: radiographic-histologic correlation.

Authors:  W J Shea; B E Demas; H I Goldberg; D C Hohn; L D Ferrell; R K Kerlan
Journal:  AJR Am J Roentgenol       Date:  1986-04       Impact factor: 3.959

View more
  1 in total

1.  Familial pancreatic enzyme insufficiency.

Authors:  G Owen; P W Buss; H R Jenkins; A H Goodwin; M C Goodchild
Journal:  Arch Dis Child       Date:  1992-12       Impact factor: 3.791

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.